SOPHiA GENETICS (SOPH) Change in Cash (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Change in Cash data on file, last reported at -$12.0 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash rose 8.31% year-over-year to -$12.0 million; the trailing twelve-month figure through Dec 2025 stood at -$14.4 million (up 63.5% YoY), and the FY2025 full-year result was -$14.4 million, up 63.5% from the prior year.
• Change in Cash advanced to -$12.0 million in Q4 2025, from -$13.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $168.8 million in Q3 2021 to a low of -$20.5 million in Q3 2022.
• A 5-year average of -$182950.0 and a median of -$12.5 million in 2021 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash slumped 1242.96% in 2023 and jumped 1610.29% in 2025, its largest moves.
• Tracing SOPH's Change in Cash over 5 years: stood at -$17.2 million in 2021, then soared by 107.16% to $1.2 million in 2022, then tumbled by 1242.96% to -$14.0 million in 2023, then rose by 6.64% to -$13.1 million in 2024, then rose by 8.31% to -$12.0 million in 2025.
• Business Quant data shows SOPH's Change in Cash at -$12.0 million in Q4 2025, -$13.4 million in Q3 2025, and $23.8 million in Q2 2025.